There were around 134,395 cases of cancer that went undiagnosed in U.S. adults during the first 10 months of 2020 due to pandemic disruptions in screening and care, research published Feb. 22 in JAMA Oncology estimates.
Oncology
HCA Sarah Cannon Cancer Institute in Nashville, Tenn., has introduced a model to monitor patients who received CAR-T cell therapy in an outpatient setting.
The FDA recently approved the first tumor-infiltrating lymphocyte, or TIL, therapy to treat advanced melanoma, and 27 institutions have so far been authorized to deliver the treatment.
Chicago-based Northwestern Medicine confirmed to Becker's that it filed applications with the state Feb. 15, seeking approval for a proposed $75 million expansion of its cancer center in Warrenville, Ill.
Jonathan Uhr, MD, a medical researcher who expanded knowledge on antibodies and cancer treatments, died of prostate cancer on Feb. 15. He was 96, The Washington Post reported.
Advertisement
The National Institutes of Health has awarded funding to eight medical groups that will become part of its inaugural Cancer Screening Research Network, an effort to advance existing knowledge about emerging cancers, early detection and treatment, it announced Feb. 21.
The University of Cincinnati Cancer Center is the first site in the Midwest to launch a phase 2 clinical trial to test a pancreatic cancer vaccine.
Francisco Esteva, MD, PhD, was appointed chief of hematology and medical oncology at three hospitals.
There may be a new tool in the arsenal of the fight against cancer — more specifically, in the fight against HPV-caused cancers, which do not respond as well to traditional treatment methods like chemotherapy or radiation.
Boston-based Mass General Brigham Cancer is promoting three of its leaders, according to a memo shared with Becker's.